WallStreetZenWallStreetZen

NASDAQ: BTMD
Biote Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BTMD stock forecasts and price targets.

Forecast return on equity

Is BTMD forecast to generate an efficient return?

Company
-78.11%
Industry
-106.02%
Market
236.85%
BTMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BTMD forecast to generate an efficient return on assets?

Company
51.04%
Industry
12.91%
BTMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BTMD earnings per share forecast

What is BTMD's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.26-71.98%
Avg 2 year Forecast
$0.29-68.62%
Avg 3 year Forecast
$1.16+27.78%
BTMD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

BTMD revenue forecast

What is BTMD's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$200.1M+2.29%
Avg 2 year Forecast
$217.1M+10.99%
Avg 3 year Forecast
$263.2M+34.51%
BTMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BTMD earnings growth forecast

How is BTMD forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
2.31%
Industry
14.83%
Market
39.85%
BTMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
BTMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
BTMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

BTMD revenue growth forecast

How is BTMD forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
9.46%
Industry
4.87%
Market
23.19%
BTMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BTMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BTMD vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
BTMD$2.13N/AN/A
AIRS$1.89N/AN/A
DCGO$0.75$1.50+101.34%Hold
JYNT$8.68N/AN/A
NAKA$0.30$4.50+1,425.42%Strong Buy
View Top Medical Care Facility Stocks

Biote Stock Forecast FAQ

What is BTMD's earnings growth forecast for 2026-2028?

(NASDAQ: BTMD) Biote's forecast annual earnings growth rate of 2.31% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 14.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.85%.

Biote's earnings in 2026 is $28,794,000.On average, 6 Wall Street analysts forecast BTMD's earnings for 2026 to be $11,643,971, with the lowest BTMD earnings forecast at $6,712,407, and the highest BTMD earnings forecast at $18,698,847. On average, 4 Wall Street analysts forecast BTMD's earnings for 2027 to be $13,041,247, with the lowest BTMD earnings forecast at $12,529,826, and the highest BTMD earnings forecast at $13,424,813.

In 2028, BTMD is forecast to generate $53,096,506 in earnings, with the lowest earnings forecast at $51,014,290 and the highest earnings forecast at $54,658,168.

If you're new to stock investing, here's how to buy Biote stock.

What is BTMD's revenue growth forecast for 2026-2028?

(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 9.46% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.19%.

Biote's revenue in 2026 is $195,645,000.On average, 7 Wall Street analysts forecast BTMD's revenue for 2026 to be $9,138,005,516, with the lowest BTMD revenue forecast at $8,100,093,936, and the highest BTMD revenue forecast at $9,972,718,392. On average, 4 Wall Street analysts forecast BTMD's revenue for 2027 to be $9,915,183,478, with the lowest BTMD revenue forecast at $8,715,626,188, and the highest BTMD revenue forecast at $11,075,470,907.

In 2028, BTMD is forecast to generate $12,016,577,711 in revenue, with the lowest revenue forecast at $11,545,339,369 and the highest revenue forecast at $12,370,006,467.

What is BTMD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: BTMD) forecast ROA is 51.04%, which is higher than the forecast US Medical Care Facilities industry average of 12.91%.

What is BTMD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: BTMD) Biote's current Earnings Per Share (EPS) is $0.91. On average, analysts forecast that BTMD's EPS will be $0.26 for 2026, with the lowest EPS forecast at $0.15, and the highest EPS forecast at $0.41. On average, analysts forecast that BTMD's EPS will be $0.29 for 2027, with the lowest EPS forecast at $0.27, and the highest EPS forecast at $0.29. In 2028, BTMD's EPS is forecast to hit $1.16 (min: $1.12, max: $1.20).

What is BTMD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: BTMD) forecast ROE is -78.11%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.